NURS 6630
Psychopharmacology
COMPREHENSIVE MIDTERM EXAMINATION
Psychopharmacologic Approaches to Treatment of Psychopathology
Walden University | College of Nursing
Summer Quarter 2026/2027
100 Questions | Graded Examination Format
Advanced Practice Nursing Education
,SECTION 1: Neurobiology and Neurotransmission
Receptor Pharmacology, Synaptic Transmission, Neurotransmitter Systems, and Neuroanatomy
Q1: A PMHNP is explaining synaptic transmission to a nursing student. The student asks which
process describes the conversion of an electrical signal into a chemical signal at the presynaptic
terminal.
A. Reuptake inhibition
B. Excitation-contraction coupling
C. Exocytosis of synaptic vesicles [CORRECT]
D. Postsynaptic receptor internalization
Correct Answer: C
Rationale: Exocytosis of synaptic vesicles is the process by which an action potential (electrical signal) triggers calcium
influx at the presynaptic terminal, causing vesicles containing neurotransmitter to fuse with the cell membrane and release
their contents into the synaptic cleft (chemical signal). Reuptake inhibition refers to blocking reabsorption of neurotransmitter
from the synaptic cleft. Excitation-contraction coupling is a muscle physiology concept. Postsynaptic receptor internalization
is a downstream regulatory event, not the initial signal conversion.
Q2: Which of the following best describes the role of serotonin (5-HT) in mood regulation and its
relevance to antidepressant pharmacotherapy?
A. Serotonin primarily enhances dopaminergic transmission in the mesolimbic pathway
B. Serotonin modulates mood, anxiety, and sleep through diffuse projections from the raphe nuclei,
and deficient serotonergic neurotransmission is implicated in depression and anxiety [CORRECT]
C. Serotonin acts exclusively as an inhibitory neurotransmitter reducing excitability in the prefrontal cortex
D. Serotonin is synthesized from dopamine via monoamine oxidase in the synaptic cleft
Correct Answer: B
Rationale: Serotonin is produced in the raphe nuclei and projects widely to cortical and limbic structures, modulating mood,
anxiety, sleep, appetite, and cognition. The monoamine hypothesis posits deficient serotonergic neurotransmission underlies
depression, which is why SSRIs and SNRIs that enhance synaptic serotonin are first-line treatments. Serotonin does not
primarily enhance mesolimbic dopaminergic transmission, is not exclusively inhibitory, and is synthesized from tryptophan
via tryptophan hydroxylase, not from dopamine.
Q3: A 42-year-old patient with MDD is prescribed an SSRI. The PMHNP explains the therapeutic
effect is related to blocking SERT. What is the primary consequence of SERT blockade?
A. Increased serotonin degradation by MAO in the presynaptic terminal
B. Increased serotonin concentration in the synaptic cleft by preventing presynaptic reuptake
[CORRECT]
C. Decreased serotonin release from presynaptic vesicles via autoreceptor activation
D. Increased postsynaptic 5-HT1A receptor downregulation within 24 hours
Correct Answer: B
Rationale: SERT is responsible for presynaptic reuptake of serotonin from the synaptic cleft. SSRIs block SERT, increasing
the concentration and duration of serotonin in the synaptic cleft. This enhanced serotonergic signaling is the primary
mechanism of SSRI efficacy. SERT blockade does not increase MAO degradation, decrease serotonin release (though acute
autoreceptor effects may transiently reduce firing), or cause postsynaptic downregulation within 24 hours.
Q4: Dopamine pathways have distinct functional roles. Which pathway is most critically associated
with positive symptoms of schizophrenia, and what is the primary pharmacological target?
, A. The nigrostriatal pathway; D3 receptor blockade
B. The mesocortical pathway; D1 receptor agonism
C. The mesolimbic pathway; D2 receptor antagonism [CORRECT]
D. The tuberoinfundibular pathway; D4 receptor modulation
Correct Answer: C
Rationale: The mesolimbic dopamine pathway, projecting from the VTA to the nucleus accumbens, is associated with
positive symptoms of schizophrenia. Hyperactivity of dopaminergic transmission in this pathway underlies hallucinations
and delusions. Antipsychotics exert their primary therapeutic effect through D2 receptor antagonism in the mesolimbic
pathway. The nigrostriatal pathway is associated with EPS. The mesocortical pathway relates to negative/cognitive
symptoms. The tuberoinfundibular pathway regulates prolactin.
Q5: A PMHNP is teaching a patient about gabapentin for neuropathic pain. The patient asks whether
gabapentin affects GABA levels. Which response is most accurate?
A. Gabapentin directly increases GABA synthesis from glutamate
B. Gabapentin binds to GABA-A receptors as a positive allosteric modulator
C. Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing
excitatory neurotransmitter release; despite its name, it does not directly affect GABA levels or
receptors [CORRECT]
D. Gabapentin inhibits GABA transaminase, increasing synaptic GABA
Correct Answer: C
Rationale: Despite its name, gabapentin does not bind GABA receptors or affect GABA synthesis, release, or degradation. It
binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium influx and release of excitatory
neurotransmitters including glutamate, substance P, and norepinephrine. Vigabatrin inhibits GABA transaminase.
Benzodiazepines act as GABA-A positive allosteric modulators.
Q6: GABA is the primary inhibitory neurotransmitter. Which best describes how benzodiazepines
enhance GABAergic neurotransmission?
A. Benzodiazepines directly activate GABA-A receptors without GABA
B. Benzodiazepines act as positive allosteric modulators at GABA-A, increasing the frequency of
chloride channel opening when GABA is bound [CORRECT]
C. Benzodiazepines increase GABA synthesis via glutamic acid decarboxylase activation
D. Benzodiazepines block GABA reuptake at the presynaptic terminal
Correct Answer: B
Rationale: Benzodiazepines are positive allosteric modulators at a specific binding site on GABA-A. They do not directly
activate the receptor alone, nor increase GABA synthesis or block reuptake. When GABA binds, benzodiazepines increase the
frequency of chloride channel opening, enhancing inhibition. Barbiturates, in contrast, increase the duration of channel
opening and can directly activate the receptor at high doses.
Q7: A neuroscience student asks about glutamate. Which statement about glutamatergic
neurotransmission is most accurate?
A. Glutamate acts primarily on metabotropic receptors with no role in fast transmission
B. Glutamate is the most abundant excitatory neurotransmitter in the CNS, acting on ionotropic
(NMDA, AMPA, kainate) and metabotropic receptors; excessive activity can cause excitotoxic damage
[CORRECT]
C. Glutamate is synthesized from GABA through GABA transaminase
D. NMDA receptor hypofunction has been implicated in anxiety disorders
Correct Answer: B
Psychopharmacology
COMPREHENSIVE MIDTERM EXAMINATION
Psychopharmacologic Approaches to Treatment of Psychopathology
Walden University | College of Nursing
Summer Quarter 2026/2027
100 Questions | Graded Examination Format
Advanced Practice Nursing Education
,SECTION 1: Neurobiology and Neurotransmission
Receptor Pharmacology, Synaptic Transmission, Neurotransmitter Systems, and Neuroanatomy
Q1: A PMHNP is explaining synaptic transmission to a nursing student. The student asks which
process describes the conversion of an electrical signal into a chemical signal at the presynaptic
terminal.
A. Reuptake inhibition
B. Excitation-contraction coupling
C. Exocytosis of synaptic vesicles [CORRECT]
D. Postsynaptic receptor internalization
Correct Answer: C
Rationale: Exocytosis of synaptic vesicles is the process by which an action potential (electrical signal) triggers calcium
influx at the presynaptic terminal, causing vesicles containing neurotransmitter to fuse with the cell membrane and release
their contents into the synaptic cleft (chemical signal). Reuptake inhibition refers to blocking reabsorption of neurotransmitter
from the synaptic cleft. Excitation-contraction coupling is a muscle physiology concept. Postsynaptic receptor internalization
is a downstream regulatory event, not the initial signal conversion.
Q2: Which of the following best describes the role of serotonin (5-HT) in mood regulation and its
relevance to antidepressant pharmacotherapy?
A. Serotonin primarily enhances dopaminergic transmission in the mesolimbic pathway
B. Serotonin modulates mood, anxiety, and sleep through diffuse projections from the raphe nuclei,
and deficient serotonergic neurotransmission is implicated in depression and anxiety [CORRECT]
C. Serotonin acts exclusively as an inhibitory neurotransmitter reducing excitability in the prefrontal cortex
D. Serotonin is synthesized from dopamine via monoamine oxidase in the synaptic cleft
Correct Answer: B
Rationale: Serotonin is produced in the raphe nuclei and projects widely to cortical and limbic structures, modulating mood,
anxiety, sleep, appetite, and cognition. The monoamine hypothesis posits deficient serotonergic neurotransmission underlies
depression, which is why SSRIs and SNRIs that enhance synaptic serotonin are first-line treatments. Serotonin does not
primarily enhance mesolimbic dopaminergic transmission, is not exclusively inhibitory, and is synthesized from tryptophan
via tryptophan hydroxylase, not from dopamine.
Q3: A 42-year-old patient with MDD is prescribed an SSRI. The PMHNP explains the therapeutic
effect is related to blocking SERT. What is the primary consequence of SERT blockade?
A. Increased serotonin degradation by MAO in the presynaptic terminal
B. Increased serotonin concentration in the synaptic cleft by preventing presynaptic reuptake
[CORRECT]
C. Decreased serotonin release from presynaptic vesicles via autoreceptor activation
D. Increased postsynaptic 5-HT1A receptor downregulation within 24 hours
Correct Answer: B
Rationale: SERT is responsible for presynaptic reuptake of serotonin from the synaptic cleft. SSRIs block SERT, increasing
the concentration and duration of serotonin in the synaptic cleft. This enhanced serotonergic signaling is the primary
mechanism of SSRI efficacy. SERT blockade does not increase MAO degradation, decrease serotonin release (though acute
autoreceptor effects may transiently reduce firing), or cause postsynaptic downregulation within 24 hours.
Q4: Dopamine pathways have distinct functional roles. Which pathway is most critically associated
with positive symptoms of schizophrenia, and what is the primary pharmacological target?
, A. The nigrostriatal pathway; D3 receptor blockade
B. The mesocortical pathway; D1 receptor agonism
C. The mesolimbic pathway; D2 receptor antagonism [CORRECT]
D. The tuberoinfundibular pathway; D4 receptor modulation
Correct Answer: C
Rationale: The mesolimbic dopamine pathway, projecting from the VTA to the nucleus accumbens, is associated with
positive symptoms of schizophrenia. Hyperactivity of dopaminergic transmission in this pathway underlies hallucinations
and delusions. Antipsychotics exert their primary therapeutic effect through D2 receptor antagonism in the mesolimbic
pathway. The nigrostriatal pathway is associated with EPS. The mesocortical pathway relates to negative/cognitive
symptoms. The tuberoinfundibular pathway regulates prolactin.
Q5: A PMHNP is teaching a patient about gabapentin for neuropathic pain. The patient asks whether
gabapentin affects GABA levels. Which response is most accurate?
A. Gabapentin directly increases GABA synthesis from glutamate
B. Gabapentin binds to GABA-A receptors as a positive allosteric modulator
C. Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels, reducing
excitatory neurotransmitter release; despite its name, it does not directly affect GABA levels or
receptors [CORRECT]
D. Gabapentin inhibits GABA transaminase, increasing synaptic GABA
Correct Answer: C
Rationale: Despite its name, gabapentin does not bind GABA receptors or affect GABA synthesis, release, or degradation. It
binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing calcium influx and release of excitatory
neurotransmitters including glutamate, substance P, and norepinephrine. Vigabatrin inhibits GABA transaminase.
Benzodiazepines act as GABA-A positive allosteric modulators.
Q6: GABA is the primary inhibitory neurotransmitter. Which best describes how benzodiazepines
enhance GABAergic neurotransmission?
A. Benzodiazepines directly activate GABA-A receptors without GABA
B. Benzodiazepines act as positive allosteric modulators at GABA-A, increasing the frequency of
chloride channel opening when GABA is bound [CORRECT]
C. Benzodiazepines increase GABA synthesis via glutamic acid decarboxylase activation
D. Benzodiazepines block GABA reuptake at the presynaptic terminal
Correct Answer: B
Rationale: Benzodiazepines are positive allosteric modulators at a specific binding site on GABA-A. They do not directly
activate the receptor alone, nor increase GABA synthesis or block reuptake. When GABA binds, benzodiazepines increase the
frequency of chloride channel opening, enhancing inhibition. Barbiturates, in contrast, increase the duration of channel
opening and can directly activate the receptor at high doses.
Q7: A neuroscience student asks about glutamate. Which statement about glutamatergic
neurotransmission is most accurate?
A. Glutamate acts primarily on metabotropic receptors with no role in fast transmission
B. Glutamate is the most abundant excitatory neurotransmitter in the CNS, acting on ionotropic
(NMDA, AMPA, kainate) and metabotropic receptors; excessive activity can cause excitotoxic damage
[CORRECT]
C. Glutamate is synthesized from GABA through GABA transaminase
D. NMDA receptor hypofunction has been implicated in anxiety disorders
Correct Answer: B
